Skip to main content

Primary Osteoarthritis of Knee Nos

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
Vanguard XP Bi-cruciate Retaining Knee Replacement SystemN/A1 trial
Active Trials
NCT03302013Unknown260Est. Jan 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Zimmer BiometVanguard XP Bi-cruciate Retaining Knee Replacement System

Clinical Trials (1)

Total enrollment: 260 patients across 1 trials

NCT03302013Zimmer BiometVanguard XP Bi-cruciate Retaining Knee Replacement System

All Ligaments Left In Knee Arthroplasty Trial

Start: Sep 2016Est. completion: Jan 2022260 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.